Breast cancer in developing countries: opportunities for improved survival.
Breast cancer survival in the USA has continually improved over the last six decades and has largely been accredited to the use of mammography, advanced surgical procedures, and adjuvant therapies. Data indicate, however, that there were substantial improvements in survival in the USA even prior to these technological and diagnostic advances, suggesting important opportunities for early detection and treatment in low- and middle-income countries where these options are often unavailable and/or unaffordable. Thus, while continuing to strive for increased access to more advanced technology, improving survival in these settings should be more immediately achievable through increased awareness of breast cancer and of the potential for successful treatment, a high-quality primary care system without economic or cultural barriers to access, and a well-functioning referral system for basic surgical and hormonal treatment.
Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.
Lawrence N
LN
Shulman
Walter
W
Willett
Amy
A
Sievers
Felicia M
FM
Knaul
Lancet. 2010 Oct 2;376(9747):1186-93
20709386
J Clin Oncol. 2001 Sep 15;19(18 Suppl):125S-127S
11560987
J Natl Cancer Inst. 2002 Oct 2;94(19):1445-57
12359854
Cancers (Basel). 2010 Sep 30;2(4):1771-8
24281200
Salud Publica Mex. 2009;51 Suppl 2:s286-95
19967284
N Engl J Med. 2008 Jan 17;358(3):213-6
18199859
Arch Intern Med. 2009 Oct 12;169(18):1650-2
19822819
Ann Oncol. 2010 Apr;21(4):680-682
20338877
Vopr Onkol. 1999;45(3):265-71
10443229
Cancer. 2008 Oct 15;113(8 Suppl):2221-43
18816619
Lancet Oncol. 2009 Nov;10(11):1029-30
19880059
Salud Publica Mex. 2009;51 Suppl 2:s309-15
19967287
J Clin Oncol. 2001 Sep 15;19(18 Suppl):106S-111S
11560984
N Engl J Med. 2010 Aug 26;363(9):801-3
20818843
Ann Oncol. 2006 Jun;17 Suppl 8:viii9-viii14
16801342
J Clin Oncol. 2005 Nov 1;23(31):7836-41
16258086
Lancet. 2006 Sep 9;368(9539):954-61
16962886
Reprod Health Matters. 2008 Nov;16(32):113-23
19027629
J Clin Oncol. 2001 Sep 15;19(18 Suppl):118S-124S
11560986